Metal Exposure Tied to Atherosclerosis Progression
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- Metal exposure from environmental pollution is associated with the progression of atherosclerosis, according to a study published online Sept. 18 in the Journal of the American College of Cardiology.
Katlyn E. McGraw, Ph.D., from the Columbia University Mailman School of Public Health in New York City, and colleagues examined whether exposure to metals from environmental pollution is related to atherosclerosis progression. The analysis included data from 6,418 participants in the Multi-Ethnic Study of Atherosclerosis.
The researchers found that for the highest to lowest quartile of urinary cadmium, coronary artery calcium (CAC) levels were 51 percent higher at baseline and 75 percent higher during the 10-year period. Corresponding CAC levels during the 10-year period were 45 percent higher for urinary tungsten, 39 percent higher for uranium, and 47 percent higher for cobalt, with no difference for models with and without adjustment for clinical factors. When adjusting for clinical factors, the corresponding estimates dropped for copper and zinc from 55 to 33 percent and from 85 to 57 percent, respectively. The associations of metals with CAC were similar in magnitude to classical cardiovascular disease risk factors.
"Our findings highlight the importance of considering metal exposure as a significant risk factor for atherosclerosis and cardiovascular disease," McGraw said in a statement. "This could lead to new prevention and treatment strategies that target metal exposure."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 06:00
Read more
- Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly
- Men Aged >16 to
- Private Balcony Hot Tubs Spread Legionnaires Disease on Cruise Ships
- Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
- Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
- IDSA: 1999 to 2019 Saw Decrease in Sepsis-Related Mortality Rate in Children
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions